|
Tuesday, March 10 — 8:00 AM — CC 309
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section H1 - ENDOCRINE
Chaired by: Ashraf Khan and Lori Erickson
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
The Role FGFR4 in Pancreatic Endocrine Tumors
(534)
S Serra, S Ezzat, R Chetty, SL Asa - UHN, Toronto, Canada
|  Add |
| 8:15 |
VHL Inactivation Is an Important Pathway for the Development of Sporadic Pancreatic Endocrine Tumors
(533)
AM Schmitt, S Schmid, T Rudolph, M Anlauf, G Kloppel, H Moch, PU Heitz, P Komminoth, A Perren - University Hospital Zurich, Zurich, Switzerland; City Hospital Triemli, Zurich, Switzerland; Klinikum Rechts der Isar, Technische Universitat Munchen, Munich, Germany; University of Kiel, Kiel, Germany
| Add |
| 8:30 |
Pancreatic Specific Transcription Factors and CK19 in Pancreatic Endocrine Tumors
(512)
L Albarello, A Zerbi, V Capitanio, L Piemonti, V Di Carlo, C Doglioni - San Raffaele Scientific Institute, Milan, Italy
| Add |
| 8:45 |
miRNA Markers of Aggressive Behavior of Papillary Thyroid Carcinoma
(526)
MN Nikiforova, JE Dipaola, LM Aspden, YE Nikiforov - University of Pittsburgh Medical Center, Pittsburgh, PA
| Add |
| 9:00 |
Stem Cell Features Segregate to the Peripheral Compartment of High-Grade Follicular Thyroid Carcinomas
(516)
H Elhassan, A Blanes, J Moorhead, SJ Diaz-Cano - King's College Hospital, London, UK; University of Malaga School of Medicine, Malaga, Spain
| Add |
| 9:15 |
Molecular Characterization of Radioactive Iodine Refractory FDG-PET Positive Thyroid Carcinoma
(531)
J Ricarte-Filho, M Rivera, RM Tuttle, JA Fagin, R Ghossein - Memorial Sloan-Kettering Cancer Center, New York
| Add |
| 9:30 |
RECESS, EXHIBITS AND POSTER SESSION III
| |
|
|
